Drug intelligence / Profile preview

IND02

Development stage: Preclinical
Lead developer: Natrusolate
Modality: Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration: Oral

Overview

IND02 is a botanical extract candidate developed by Natrusolate, specifically standardized for Type A polyphenols. It is designed to support immune system health and enhance physical performance and recovery in the context of endurance training. Type A polyphenols are a specific class of flavonoids known for their potent antioxidant and anti-inflammatory activities. By modulating oxidative stress and inflammatory markers, IND02 aims to mitigate the physiological strain of intense exercise and bolster the body's natural defenses.

Other names: Type A Polyphenols botanical extract

Targets

SA (Sialic acid)HS (Heparan sulfate)gp120 (HIV-1 envelope glycoprotein (gp120/gp41) epitopes)SELP (P-selectin)SELE (E-selectin)SELL (L-selectin)

Beyond the preview

Go deeper on IND02.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on IND02.

Explore the full profile